Author Question: What is the key to recognizing obstructive sleep apnea when the results of a sleep study are ... (Read 47 times)

viki

  • Hero Member
  • *****
  • Posts: 525
What is the key to recognizing obstructive sleep apnea when the results of a sleep study are ana-lyzed?
 
  a. No airflow and no respiratory effort
  b. No airflow with increasing respiratory ef-fort
  c. Reduced airflow with minimal respiratory effort
  d. No airflow with no or minimal respiratory effort

Question 2

Which of the following represents the polysomnographic tracing of a patient with central sleep apnea?
 
  a.
  b.
  c.
  d.



nickk12214

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

ANS: B
The finding of no airflow with increasing respiratory effort is needed to diagnose obstructive sleep apnea.

Answer to Question 2

ANS: D
The polysomnographic tracing of a patient with central sleep apnea shows a complete cessation of nasal and oral airflow during the apneic episode.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library